Michael Vaphiades is a Neurology physician affiliated with University of Alabama at Birmingham Hospital. OpenAlex indexes 232 publications with 1,980 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
700 18th St S
Suite 601
Birmingham, AL 352331856
Telephone
206-325-8620Provider last certified this registry record 19 Aug 2020.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year20258 payments
- ABBVIE INC.Program year20254 payments
- ANI Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
97.5%Neuromuscular Blocker97.5%Onabotulinumtoxina100%Part B, office-administered≥98 patientsNervous system
1.2%Cholinesterase Inhibitor0.7%Pyridostigmine Bromide92%Pyridostigmine Bromide Er8%Part D<11 patientsGabapentinoids0.2%Gabapentin100%Part D<11 patients+ 2 more classes in this area
Sensory organs
0.5%Carbonic Anhydrase Inhibitor0.5%Acetazolamide59%Acetazolamide Er31%Dorzolamide-Timolol10%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Superior ophthalmic vein thrombosis: What radiologist and clinician must know?
European Journal of Radiology Open
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Shelton
University of Alabama at Birmingham Hospital
Marc Passman
University of Alabama at Birmingham Hospital
Rebecca Arend, MD
University of Alabama at Birmingham Hospital
Matthew Stoll, MD, PhD
University of Alabama at Birmingham Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”